ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,934Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 663

$905K Total Retail Price of All Prescriptions

Rank: 11 out of 663

251 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 251 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 251 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 10,062 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
NEXIUM 536 515 1 43
CRESTOR 433 385 2 37
LEVOTHYROXINE SODIUM 347 330 3 3
ZOLPIDEM TARTRATE 291 255 4 16
LISINOPRIL 276 262 5 2
FUROSEMIDE 276 270 5 7
ATORVASTATIN CALCIUM 257 252 7 13
METFORMIN HCL ER 255 241 8 90
SIMVASTATIN 252 232 9 1
TAMSULOSIN HCL 215 209 10 24
METOPROLOL SUCCINATE 212 209 11 25
POTASSIUM CHLORIDE 209 197 12 23
AMLODIPINE BESYLATE 203 202 13 5
LOSARTAN POTASSIUM 190 172 14 14
LOSARTAN-HYDROCHLOROTHIAZIDE 166 154 15 60
LIPITOR 163 163 16 72
ALLOPURINOL 161 161 17 28
WARFARIN SODIUM 156 149 18 8
BYSTOLIC 153 139 19 116
OMEPRAZOLE 150 135 20 4
HYDROCHLOROTHIAZIDE 149 133 21 12
DIOVAN 132 126 22 59
LIDODERM 132 119 22 67
ADVAIR DISKUS 127 112 24 53
ZETIA 126 105 25 80
FLUTICASONE PROPIONATE 122 108 26 27
HYDROCODONE-ACETAMINOPHEN 120 84 S3 27 6
SPIRIVA 118 109 28 62
CARVEDILOL 115 115 29 47
METFORMIN HCL 109 99 30 9
HYDRALAZINE HCL 104 101 31 101
DIOVAN HCT 103 95 32 115
METOPROLOL TARTRATE 100 100 33 11
JANUVIA 98 85 34 78
RANITIDINE HCL 92 82 35 31
GABAPENTIN 91 81 36 20
CLOPIDOGREL 85 72 37 65
ATENOLOL 82 82 38 10
NAMENDA 81 81 39 57
AVODART 81 74 39 195
ALENDRONATE SODIUM 79 79 41 15
CITALOPRAM HBR 78 67 42 18
NITROSTAT 77 72 43 152
VOLTAREN 76 76 44 107
FINASTERIDE 73 73 45 56
CELEBREX 70 55 46 85
PLAVIX 69 62 47 104
ESCITALOPRAM OXALATE 63 55 48 77
AGGRENOX 63 63 48 175
CREON 63 63 48 153
ACTOS 61 52 51 105
MECLIZINE HCL 58 55 52 136
CYMBALTA 57 51 53 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 54 22
PRADAXA 51 51 55 192
DONEPEZIL HCL 50 46 56 40
TRAMADOL HCL 50 45 56 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.